Photodynamic therapy in dermatology: State-of-the-art

Photodermatology Photoimmunology and Photomedicine

Volumn 26, Issue 3, 2010, Pages 118-132

  Babilas, Philipp ^a   Schreml, Stephan ^a   Landthaler, Michael ^a   Szeimies, Rolf Markus ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Aminolevulinic acid; Inflammation; Methyl aminolevulinate; Photodynamic therapy; Skin cancer

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; DICLOFENAC; DITHRANOL; EMLA; EOSIN RED; ERYTHROSINE; FLUORESCENT DYE; FLUOROURACIL; IMIQUIMOD; LIDOCAINE; PAROMOMYCIN; PHOTOFRIN; PHOTOSENSITIZING AGENT; PODOPHYLLIN; UNCLASSIFIED DRUG; VERTEPORFIN;

ABSENCE OF SIDE EFFECTS; ACNE VULGARIS; ACTINIC KERATOSIS; APPLICATION SITE HYPERPIGMENTATION; BASAL CELL CARCINOMA; BLISTER; BLUE LIGHT; BOWEN DISEASE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CRYOSURGERY; CRYOTHERAPY; DEEP TISSUE NECROSIS; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG MECHANISM; DRUG METABOLISM; DRUG PENETRATION; EDEMA; ERYTHEMA; GRANULOMA ANNULARE; HUMAN; HYPOPIGMENTATION; INTENSE PULSED LIGHT; LICHEN SCLEROSUS ET ATROPHICUS; LIGHT EMITTING DIODE; LUPUS VULGARIS; MOLLUSCUM CONTAGIOSUM; MORPHEA; NONHUMAN; PAIN; PHOTOAGING; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHOTOTHERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PSORIASIS VULGARIS; PURPURA; PUVA; RASH; RED LIGHT; REVIEW; SCAR; SCLERODERMA; SEBACEOUS GLAND DISEASE; SEBACEOUS GLAND HYPERPLASIA; SKIN BURNING SENSATION; SKIN CANCER; SKIN CARCINOMA; SKIN DEFECT; SKIN LEISHMANIASIS; SQUAMOUS CELL CARCINOMA; SYPHILIS; TINEA VERSICOLOR; TISSUE NECROSIS; TOPICAL TREATMENT; TREATMENT INDICATION; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT; VERRUCA PLANTARIS; VERRUCA VULGARIS; VULGAR WART; WART VIRUS; PHOTOCHEMOTHERAPY; SKIN DISEASES;

HUMANS; PHOTOCHEMOTHERAPY; SKIN DISEASES;

EID: 77954077570     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2010.00507.x     Document Type: Review

References (120)

1. Szeimies RM, Dräger J, Abels C, Landthaler M. History of photodynamic therapy in dermatology. Photodynamic therapy and fluorescence diagnosis in dermatology 2001, 3-16. Amsterdam, Elsevier
2. von Tappeiner H. Über die wirkung fluorescierender stoffe auf infusorien: nach Versuchen von O. Raab. MMW 1900, 47:5-7.
3. Dougherty TJ, Grindey GB, Fiel R, Weishaupt KR, Boyle DG. Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 1975, 55:115-121.
4. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978, 38:2628-2635.
5. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 2004, 30:264-271.
6. Braathen LR. Photodynamic therapy. Tidsskr Nor Laegeforen 2001, 121:2635-2636.
7. Dragieva G, Hafner J, Dummer R. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004, 77:115-121.
8. Dragieva G, Prinz BM, Hafner J. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004, 151:196-200.
9. Morton CA. Photodynamic therapy for nonmelanoma skin cancer-and more? Arch Dermatol 2004, 140:116-120.
10. Schweitzer VG. Photofrin-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med 2001, 29:305-313.
11. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990, 6:143-148.
12. Zeitouni NC, Oseroff AR, Shieh S. Photodynamic therapy for nonmelanoma skin cancers.Current review and update. Mol Immunol 2003, 39:1133-1136.
13. Szeimies RM, Karrer S, Abels C, Landthaler M, Elmets C. Photodynamic therapy in dermatology. Dermatological phototherapy and photodiagnostic methods 2001, 209-247. Berlin, Springer
14. Juzeniene A, Juzenas P, Iani V, Moan J. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem Photobiol 2002, 76:329-334.
15. Christiansen K, Bjerring P, Troilius A. 5-ALA for photodynamic photorejuvenation-optimization of treatment regime based on normal-skin fluorescence measurements. Lasers Surg Med 2007, 39:302-310.
16. Hauschild A, Stockfleth E, Popp G. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol 2009, 160:1066-1074.
17. Baas P, Saarnak AE, Oppelaar H, Neering H, Stewart FA. Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study. Br J Dermatol 2001, 145:75-78.
18. Lui H, Hobbs L, Tope WD. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes. Arch Dermatol 2004, 140:26-32.
19. Brown SB. The role of light in the treatment of non-melanoma skin cancer using methyl aminolevulinate. J Dermatolog Treat 2003, 1((Suppl. 3)):11-14.
20. Szeimies RM, Abels C, Fritsch C. Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. J Invest Dermatol 1995, 105:672-677.
21. Piacquadio DJ, Chen DM, Farber HF. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol 2004, 140:41-46.
22. Morton CA, Brown SB, Collins S. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology group. Br J Dermatol 2002, 146:552-567.
23. Morton CA, Whitehurst C, Moore JV, MacKie RM. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 2000, 143:767-772.
24. Haller JC, Cairnduff F, Slack G. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 2000, 143:1270-1275.
25. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001, 145:467-471.
26. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000, 142:338-339.
27. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci 2002, 17:173-186.
28. Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci 2004, 19:139-149.
29. Karrer S, Baumler W, Abels C, Hohenleutner U, Landthaler M, Szeimies RM. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med 1999, 25:51-59.
30. Szeimies RM, Hein R, Baumler W, Heine A, Landthaler M. A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol 1994, 74:117-119.
31. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 2003, 139:1313-1320.
32. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Carter LN. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris. J Drugs Dermatol 2004, 3:S15-S19.
33. Melnick S. Cystic acne improved by photodynamic therapy with short-contact 5-aminolevulinic acid and sequential combination of intense pulsed light and blue light activation. J Drugs Dermatol 2005, 4:742-745.
34. Santos MA, Belo VG, Santos G. Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone in the treatment of acne vulgaris: comparative study. Dermatol Surg 2005, 31:910-915.
35. Avram DK, Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol 2004, 3:S36-S39.
36. Kim HS, Yoo JY, Cho KH, Kwon OS, Moon SE. Topical photodynamic therapy using intense pulsed light for treatment of actinic keratosis: clinical and histopathologic evaluation. Dermatol Surg 2005, 31:33-36. discussion 36-37
37. Alster TS, Tanzi EL, Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol 2005, 4:35-38.
38. Dover JS, Bhatia AC, Stewart B, Arndt KA. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol 2005, 141:1247-1252.
39. Goldman MP, Weiss RA, Weiss MA. Intense pulsed light as a nonablative approach to photoaging. Dermatol Surg 2005, 31:1179-1187. discussion 1187
40. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Lewis TL. Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. J Drugs Dermatol 2004, 3:S6-S9.
41. Babilas P, Kohl E, Maisch T. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol 2006, 154:712-718.
42. Babilas P, Knobler R, Hummel S. Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. Br J Dermatol 2007, 157:111-117.
43. Babilas P, Travnik R, Werner A, Landthaler M, Szeimies RM. Split-face-study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the LED system. J Dtsch Dermatol Ges 2008, 6:25-32.
44. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003, 19:134-141.
45. Varma S, Wilson H, Kurwa HA. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol 2001, 144:567-574.
46. Yang CH, Lee JC, Chen CH, Hui CY, Hong HS, Kuo HW. Photodynamic therapy for bowenoid papulosis using a novel incoherent light-emitting diode device. Br J Dermatol 2003, 149:1297-1299.
47. Morton CA. Methyl aminolevulinate (Metvix) photodynamic therapy - practical pearls. J Dermatolog Treat 2003, 14((Suppl. 3)):23-26.
48. Wolf P, Fink-Puches R, Reimann-Weber A, Kerl H. Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. Dermatology 1997, 194:53-54.
49. Schreml S, Gantner S, Steinbauer J, Babilas P, Landthaler M, Szeimies RM. Melanoma promotion after photodynamic therapy of a suspected Bowen's disease lesion. Dermatology 2009, 219:279-281.
50. Bissonette R, Bergeron A, Liu Y. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. J Drugs Dermatol 2004, 3:S26-S31.
51. Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol 1997, 66:493-496.
52. Moore JV, Allan E. Pulsed ultrasound measurements of depth and regression of basal cell carcinomas after photodynamic therapy: relationship to probability of 1-year local control. Br J Dermatol 2003, 149:1035-1040.
53. Foley P. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. J Dermatolog Treat 2003, 14((Suppl. 3)):15-22.
54. Szeimies RM, Karrer S, Radakovic-Fijan S. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002, 47:258-262.
55. Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004, 140:33-40.
56. Pagliaro J, Elliott T, Bulsara M, King C, Vinciullo C. Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen's disease: an effective addition to treatment: a pilot study. Dermatol Surg 2004, 30:63-66.
57. Holmes MV, Dawe RS, Ferguson J, Ibbotson SH. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol 2004, 150:337-340.
58. Moloney FJ, Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 2007, 157:87-91.
59. Rodriguez L, Batlle A, Di Venosa G. Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells. Br J Pharmacol 2006, 147:825-833.
60. Steinbauer JM, Schreml S, Babilas P. Topical photodynamic therapy with porphyrin precursors - assessment of treatment-associated pain in a retrospective study. Photochem Photobiol Sci 2009, 8:1111-1116.
61. Sandberg C, Stenquist B, Rosdahl I. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 2006, 86:404-408.
62. Lehmann P. Side effects of topical photodynamic therapy. Hautarzt 2007, 58:597-603.
63. Wulf HC, Philipsen P. Allergic contact dermatitis to 5-aminolaevulinic acid methylester but not to 5-aminolaevulinic acid after photodynamic therapy. Br J Dermatol 2004, 150:143-145.
64. Guillen C, Sanmartin O, Escudero A, Botella-Estrada R, Sevila A, Castejon P. Photodynamic therapy for in situ squamous cell carcinoma on chronic radiation dermatitis after photosensitization with 5-aminolaevulinic acid. J Eur Acad Dermatol Venereol 2000, 14:298-300.
65. Babilas P, Landthaler M, Szeimies RM. Actinic keratoses. Hautarzt 2003, 54:551-560. quiz 561-552
66. Braathen LR, Szeimies RM, Basset-Seguin N. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007, 56:125-143.
67. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008, 159:1245-1266.
68. Freeman M, Vinciullo C, Francis D. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003, 14:99-106.
69. Pariser DM, Lowe NJ, Stewart DM. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003, 48:227-232.
70. Morton C, Campbell S, Gupta G. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006, 155:1029-1036.
71. Morton CA, Whitehurst C, McColl JH, Moore JV, MacKie RM. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol 2001, 137:319-324.
72. Horn M, Wolf P, Wulf HC. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003, 149:1242-1249.
73. Rhodes LE, de Rie M, Enstrom Y. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004, 140:17-23.
74. Wang I, Bendsoe N, Klinteberg CA. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001, 144:832-840.
75. Basset-Seguin N, Ibbotson SH, Emtestam L. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008, 18:547-553.
76. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 2007, 156:793-801.
77. Kuijpers DI, Smeets NW, Krekels GA, Thissen MR. Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with Mohs micrographic surgery. Dermatol Surg 2004, 30:794-798.
78. Szeimies RM, Ibbotson S, Murrell DF. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008, 22:1302-1311.
79. Salim A, Leman JA, McColl JH, Chapman R, Morton CA. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003, 148:539-543.
80. Morton C, Horn M, Leman J. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 2006, 142:729-735.
81. Hayami J, Okamoto H, Sugihara A, Horio T. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid. J Dermatol 2007, 34:320-327.
82. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol 2004, 151:776-783.
83. Karrer S, Szeimies RM. Photodynamic therapy: non-oncologic indications]. Hautarzt 2007, 58:585-596.
84. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 2002, 146:178-188.
85. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 2001, 144:575-579.
86. Karrer S, Abels C, Landthaler M, Szeimies RM. Topical photodynamic therapy for localized scleroderma. Acta Derm Venereol 2000, 80:26-27.
87. Stender IM, Na R, Fogh H, Gluud C, Wulf HC. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet 2000, 355:963-966.
88. Bissonnette R, Zeng H, McLean DI, Korbelik M, Lui H. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells. Photochem Photobiol 2001, 74:339-345.
89. Stringer MR, Collins P, Robinson DJ, Stables GI, Sheehan-Dare RA. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J Invest Dermatol 1996, 107:76-81.
90. Boehncke WH, Sterry W, Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 1994, 343:801.
91. Collins P, Robinson DJ, Stringer MR, Stables GI, Sheehan-Dare RA. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997, 137:743-749.
92. Robinson DJ, Collins P, Stringer MR. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol 1999, 79:451-455.
93. Beattie PE, Dawe RS, Ferguson J, Ibbotson SH. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrowband UVB phototherapy. Clin Exp Dermatol 2004, 29:560-562.
94. Radakovic-Fijan S, Blecha-Thalhammer U, Schleyer V. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol 2005, 152:279-283.
95. Schleyer V, Radakovic-Fijan S, Karrer S. Disappointing results and low tolerability of photodynamic therapy with topical 5-aminolaevulinic acid in psoriasis.A randomized, double-blind phase I/II study. J Eur Acad Dermatol Venereol 2006, 20:823-828.
96. Stender IM, Wulf HC. Kobner reaction induced by photodynamic therapy using delta-aminolevulinic acid: a case report. Acta Derm Venereol 1996, 76:392-393.
97. Brentjens MH, Yeung-Yue KA, Lee PC, Tyring SK. Human papillomavirus: a review. Dermatol Clin 2002, 20:315-331.
98. Fehr MK, Chapman CF, Krasieva T. Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. Am J Obstet Gynecol 1996, 174:951-957.
99. Ross EV, Romero R, Kollias N, Crum C, Anderson RR. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Br J Dermatol 1997, 137:736-742.
100. Smetana Z, Malik Z, Orenstein A, Mendelson E, Ben-Hur E. Treatment of viral infections with 5-aminolevulinic acid and light. Lasers Surg Med 1997, 21:351-358.
101. Ammann R, Hunziker T, Braathen LR. Topical photodynamic therapy in verrucae. A pilot study. Dermatology 1995, 191:346-347.
102. Stender IM, Lock-Andersen J, Wulf HC. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: a pilot study. Clin Exp Dermatol 1999, 24:154-159.
103. Fabbrocini G, Di Costanzo MP, Riccardo AM. Photodynamic therapy with topical delta-aminolaevulinic acid for the treatment of plantar warts. J Photochem Photobiol B 2001, 61:30-34.
104. Frank RG, Bos JD. Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. Genitourin Med 1996, 72:70-71.
105. Szeimies RM, Schleyer V, Moll I, Stocker M, Landthaler M, Karrer S. Adjuvant photodynamic therapy does not prevent recurrence of condylomata acuminata after carbon dioxide laser ablation-A phase III, prospective, randomized, bicentric, double-blind study. Dermatol Surg 2009, 35:757-764.
106. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000, 115:183-192.
107. Pollock B, Turner D, Stringer MR. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol 2004, 151:616-622.
108. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol 2006, 154:969-976.
109. Horfelt C, Funk J, Frohm-Nilsson M, Wiegleb Edstrom D, Wennberg AM. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Br J Dermatol 2006, 155:608-613.
110. Seyger MM, van den Hoogen FH, de Boo T, de Jong EM. Reliability of two methods to assess morphea: skin scoring and the use of a durometer. J Am Acad Dermatol 1997, 37:793-796.
111. Rook AH, Freundlich B, Jegasothy BV. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol 1992, 128:337-346.
112. Hillemanns P, Untch M, Prove F, Baumgartner R, Hillemanns M, Korell M. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 1999, 93:71-74.
113. Uebelhoer NS, Dover JS. Photodynamic therapy for cosmetic applications. Dermatol Ther 2005, 18:242-252.
114. Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S. Photodynamic photorejuvenation. Dermatol Surg 2002, 28:742-744. discussion 744
115. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 2006, 32:795-801. discussion 801-793
116. Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol 2006, 31:634-637.
117. Enk CD, Fritsch C, Jonas F. Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol 2003, 139:432-434.
118. Gardlo K, Hanneken S, Ruzicka T, Neumann NJ. Photodynamic therapy of cutaneous leishmaniasis. A promising new therapeutic modality. Hautarzt 2004, 55:381-383.
119. Gardlo K, Horska Z, Enk CD. Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol 2003, 48:893-896.
120. Stojiljkovic I, Evavold BD, Kumar V. Antimicrobial properties of porphyrins. Expert Opin Investig Drugs 2001, 10:309-320.